Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kiso, Tetsuo
75  Ergebnisse:
Personensuche X
?
1

A KCa3.1 Channel Opener, ASP0819, Modulates Nociceptive Sig..:

Takeshita, Nobuaki ; Oe, Tomoya ; Kiso, Tetsuo.
Journal of Pain Research.  14 (2021)  - p. 23-34 , 2021
Link: https://doi.org/10.2147/..
 
?
2

A KCa3.1 Channel Opener, ASP0819, Modulates Nociceptive Sig..:

Takeshita, Nobuaki ; Oe, Tomoya ; Kiso, Tetsuo.
info:eu-repo/semantics/altIdentifier/doi/10.2147/JPR.S274563.  , 2021
Link: https://www.dovepress.co..
 
?
3

A K(Ca)3.1 Channel Opener, ASP0819, Modulates Nociceptive S..:

Takeshita, Nobuaki ; Oe, Tomoya ; Kiso, Tetsuo.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811477/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
4

Forkhead Box M1 Transcription Factor Drives Liver Inflammat..:

Kurahashi, Tomohide ; Yoshida, Yuichi ; Ogura, Satoshi...
Cellular and Molecular Gastroenterology and Hepatology.  9 (2020)  3 - p. 425-446 , 2020
Link: https://doi.org/10.1016/..
 
?
5

ASP8477, a fatty acid amide hydrolase inhibitor, exerts ana..:

Kiso, Tetsuo ; Watabiki, Tomonari ; Sekizawa, Toshihiro
European Journal of Pharmacology.  881 (2020)  - p. 173194 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Forkhead Box M1 Transcription Factor Drives Liver Inflammat..:

Tomohide Kurahashi ; Yuichi Yoshida ; Satoshi Ogura...
http://www.sciencedirect.com/science/article/pii/S2352345X19301444.  , 2020
Link: https://doi.org/10.1016/..
 
?
7

Forkhead Box M1 Transcription Factor Drives Liver Inflammat..:

Kurahashi, Tomohide ; Yoshida, Yuichi ; Ogura, Satoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016284/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
8

Design, synthesis, and biological evaluation of novel biphe..:

Oka, Hiromasa ; Yonezawa, Koichi ; Kamikawa, Akio...
Bioorganic & Medicinal Chemistry.  26 (2018)  12 - p. 3716-3726 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Effects of pregabalin and duloxetine on neurotransmitters i..:

Kiso, Tetsuo ; Moriyama, Ai ; Furutani, Masako..
European Journal of Pharmacology.  827 (2018)  - p. 117-124 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Analgesic effects of ASP3662, a novel 11β‐hydroxysteroid de..:

Kiso, Tetsuo ; Sekizawa, Toshihiro ; Uchino, Hiroshi..
British Journal of Pharmacology.  175 (2018)  19 - p. 3784-3796 , 2018
Link: https://doi.org/10.1111/..
 
?
11

Targeting the mevalonate pathway is a novel therapeutic app..:

Ogura, Satoshi ; Yoshida, Yuichi ; Kurahashi, Tomohide...
Oncotarget.  9 (2018)  30 - p. 21022-21035 , 2018
Link: https://doi.org/10.18632..
 
?
12

Analgesic effects of ASP3662, a novel 11β‐hydroxysteroid de..:

Kiso, Tetsuo ; Sekizawa, Toshihiro ; Uchino, Hiroshi..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135787/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
13

Increased expression of Forkhead box M1 transcription facto..:

Egawa, Mayumi ; Yoshida, Yuichi ; Ogura, Satoshi...
Hepatology Research.  47 (2017)  11 - p. 1196-1205 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Analgesic effects of novel lysophosphatidic acid receptor 5..:

Murai, Nobuhito ; Hiyama, Hideki ; Kiso, Tetsuo...
Neuropharmacology.  126 (2017)  - p. 97-107 , 2017
Link: https://doi.org/10.1016/..
 
?
15

In vitro and in vivo pharmacological characterization of AS..:

Watabiki, Tomonari ; Tsuji, Noriko ; Kiso, Tetsuo...
European Journal of Pharmacology.  815 (2017)  - p. 42-48 , 2017
Link: https://doi.org/10.1016/..
 
1-15